A class effect of quinolone antibacterial agents observed during animal toxicity testing is a specific arthropathy (QAP). Despite the growing list of laboratory animals susceptible to QAP and reports of arthralgia in patients treated with quinolones, the potential for QAP development in humans remains unknown. This review discusses current concepts in the biology of articular cartilage and how these concepts elucidate QAP pathogenesis. Biomechanical forces within synovial joints and toxicokinetic properties of quinolones contribute to QAP induction. Since a limited number of mechanistic pathways exist for acute articular damage, QAP may serve as a research tool to probe the pathobiology of injury to articular cartilage.
Adam D. (1989). Use of quinolones in pediatric patients. Rev. Infect. Dis.II(suppl. 5): S1113-S1116.
2.
Alfaham M., Holt ME, and Goodchild MC (1987). Arthropathy in a patient with cystic fibrosis taking ciprofloxacin. Br. Med. J. 295: 699.
3.
Amacher DE, Schomaker SJ, Gootz TD, and McGuirk PR (1989). Proteoglycan and procollagen syntheses in rat embryo limb bud cultures treated with quinolone antibacterials In: In Vitro Toxicology: New Directions, Vol. 7, A Goldberg (ed). Leibert, New York, pp. 307-312.
Ayedelotte MB , Greenhill RR, and Kuettner KE (1988). Differences between subpopulations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism. Connect. Tissue Res. 18: 233-234.
6.
Ayedelotte MB and Kuettner KE (1988). Differences between subpopulations of cultured bovine articular chondrocytes. Connect. Tissue Res. 18: 205-222.
7.
Azzo W. and Woessner JF Jr (1986). Purification and characterization of an acid metalloproteinase from human articular cartilage. J. Biol. Chem. 261: 5434-5441.
8.
Bailey RR, Kirk JA, and Peddie BA (1983). Norfloxacin-induced rheumatic disease. N. Z. Med. 96: 590.
9.
Bailey RR, Natale R., and Linton AL (1972). Nalidixic acid arthralgia. Can. Med. Assoc. J. 107: 604-607.
10.
Baker JR, Caterson B., and Christner JE (1981). The link proteins of cartilage proteoglycan aggregates: Structure and function. Ala. J. Med. Sci. 18: 46-51.
11.
Bendele AM, Hulman JF, Harvey AK, Hrubey PD, and Chandrasekhar S. (1990). Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs. Toxicol. Pathol. 18(2): 304-312.
12.
Bendele AM and White SL (1987). Early histopathologic and ultrastructural alteration in femorotibial joints of partial meniscectomized guinea pigs. Vet. Pathol. 24: 436-443.
13.
Bland JH and Cooper SM (1984). Osteoarthritis: A review of the cell biology involved and evidence for reversibility. Management rationally related to known genesis and pathophysiology. Semin. Arthritis Rheum. 14(2): 106-132.
14.
Bollet AJ, Handy JR, and Sturgill BC (1963). Chondroitin sulfate concentration and protein-polysaccharide composition of articular cartilage in osteoarthritis. J. Clin. Invest. 42: 853-859.
15.
Bonucci E. and Motta PM (1990). Bone and cartilage in health and disease In: Ultrastructure of Skeletal Tissues, 1st ed, E Bonucci (ed). Kluwer Academic Publishers, Boston, p. 299.
16.
Bouissou H. , Caujolle D., Caujolle F., and Milhaud G. (1978). Toxicologie experimental-tissue cartilaglneus et acide nalidixique. C. R. Acad. Sci. [III] 286: 1743-1746.
17.
Brandt HS, Van Kampen GP, and Van der Korst JK (1990). Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage. Clin. Exp. Rheum. 8: 393-395.
18.
Broom ND (1988). An enzymatically induced structural transformation in articular cartilage. Its significance with respect to matrix breakdown. Arthritis Rheum. 31: 210-218.
19.
Burkhardt JE , Hill MA, Carlton WW, and Kesterson JW (1990). Histologic and histochemical changes in articular cartilage of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet. Pathol . 27(3): 162-170.
20.
Burkhardt JE , Hill MA, Turek JJ, and Carlton WW (1992). Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone . Vet. Pathol . 29: 230-238.
21.
Caplan A. (1984). Cartilage. Sci. Am. 251: 84-97.
22.
Carney SL and Miur H. (1988). The structure and function of cartilage proteoglycans . Physiologic Rev. 63(3): 858-910.
23.
Castora FJ, Vissering FF, and Simpson MV (1983). The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria. Biochim. Biophys. Acta740: 417-427.
24.
Chevais M., Reinert P., Rondeau MC, Tobelem R., Albengres E., Riant P., and Tillement JP (1987). Critical risk/benefit analysis of pefloxacine use in children under 15 years-The problem of arthralgias. Int. J. Clin. Pharmacol. Ther. Toxicol. 25(6): 306-309.
25.
Christ W., Lehnert T., and Ulbrich B. (1988). Specific toxicologic aspects of the quinolones . Rev. Infect. Dis.10(suppl): S144-S146.
26.
Chysky V., Kapila K., Hullmann R., Arcieri G., Schacht P., and Echols R. (1991). Safety of ciprofloxacin in children-Worldwide clinical experience based on compassionate use-emphasis on joint evaluation . Infection19: 289-296.
27.
de la Iglesia FA and Gough AW (1985). Pathology of canine drug-induced arthropathy. Fed. Proc. 44(1): 519.
28.
Dingle JT, Blow AMJ, Barrett AJ, and Martin PE (1977). Proteoglycan-degrading enzymes. A radiochemical assay method and the detection of a new enzyme, cathepsin F. Biochem. J. 167: 775-785.
29.
Doege KJ, Saski M., Kimura T., and Yamada Y. (1991). Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycans, aggrecan. J. Biol. Chem. 266(2): 894-902.
30.
Douidar SM and Snodgrass WR (1989). Potential role of fluoroquinolones in pediatric infections. Rev. Infect. Dis. 11(6): 878-889.
31.
Eyre DR, Dickson IR, and Van Ness K. (1988). Collagen crosslinking in human bone and articular cartilage. Biochem. J. 252:495-500.
32.
Ghadially FN (1983). Fine Structure of Synovial Joints, 1sted. Butterworths , London, p. 333.
33.
Ghosh P., Burkhardt D., Read R., and Bellenger C. (1991). Recent advances in animal models for evaluating chondroprotective drug. J. Rheumatol. Suppl. 27: 143-146.
34.
Gough AW, Barsoum NJ, Mitchell L., McGuire EJ, and de la Iglesia FA (1979). Juvenile canine drug-induced arthropathy: Clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol. Appl. Pharmacol. 51: 177-187.
35.
Gough AW, Barsoum NJ, Renlund RC, Sturgess JM, and de la Iglesia FA (1985). Fine structural changes during reparative phase of canine drug-induced arthropathy. Vet. Pathol. 22: 82-84.
36.
Gough AW and de la Iglesia FA (1979). A semiquantitative method to evaluate drug-induced juvenile arthropathy in the canine. Toxicol. Pathol. 7: 6-9.
37.
Green WT Jr (1971). Behavior of articular chondrocytes in cell culture. Clin. Orthop. 75: 248-260.
38.
Grenier B. (1989). Use of the new quinolones in cystic fibrosis. Rev. Infect. Dis.II(suppl. 5): S1245-S1252.
39.
Hall MC (1963). Cartilage changes after experimental immobilization of the knee joint of the young rat. J. Bone Joint Surg. 45A: 36-44.
40.
Hascall VC (1981). Proteoglycans: Structure and function. In: Biology of Carbohydrates, Vol. 1, V Ginsburg (ed). John Wiley , New York, pp. 1-49.
41.
Hasty K., Reife R., Kang A., and Stuart J. (1990). The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum. 33(3): 388-397.
42.
Heinegard D. and Oldlberg A. (1989). Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J. 3: 2042-2051.
43.
Heinegard D. and Paulsson M. (1984). Structure and metabolism of proteoglycans. In: Extracellular Matrix Biochemistry , KA Piez and A Reddi (eds). Elsevier Science Publishing, Amsterdam, pp. 277-328.
44.
Hill MA, Ruth GR, Van Sickle DC, Hilley HD, Torrison JL, Bagent JK, and Leman AD (1987). Histochemical morphologic features of growth cartilage in long bones of pigs of various ages. Am. J. Vet. Res. 48(10): 1477-1484.
45.
Howard LC, Van Sickle DC, Deshmukh K., Griffing WJ, and Owen NV (1979). Cinoxacin induced arthropathy in juvenile beagle dogs. Toxicol. Appl. Pharmacol.48: A145.
46.
Ingham B., Brentnall DW, Dale EA, and McFadzean JA (1977). Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicol. Lett. 1: 21-26.
47.
Jeandel C., Manclaux AM, Bannwarth B., Pere P., Penin F., Netter P., and Cuny G. (1989). Arthritis induced by norfloxacin. J. Rheum. 16: 560-561.
48.
Kato M. and Onondera T. (1988). Effect of ofloxacin on the uptake of [3H] thymidine by articular cartilage cells in the rat. Toxicol. Lett. 44: 131-142.
49.
Kato M. and Onodera T. (1988). Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fundam. Appl. Toxicol. 11: 110-119.
50.
Keller H. (1991). Comparisons of the adverse effect profile of different substances such as penicillins, tetracyclines, sulfonamides and quinolones . Infection19(suppl.1): S19-S24.
51.
Kincaid SA and Van Sickle DC (1981). Regional histochemical and thickness variations of adult canine articular cartilage. Am. J. Vet. Res. 42: 428-432.
52.
Kincaid SA, Van Sickle DC, and Wilsman N. (1972). Histochemical evidence of a functional heterogeneity of the chondrocytes of adult canine articular cartilage. Histochem. J. 4:237-243.
53.
Kirby CP (1984). Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin. J. Antimicrob. Chemother. (suppl. B) 13: 107-112.
54.
Kiviranta I. , Tammi M., Jurvelin J., Saamanen AM, Arokoski J., and Helminen HJ (1988). Joint loading influences on the articular cartilage of young dogs . J. Histochem. Cytochem . 36(7A): 867.
55.
Korver G., Van de Stadt R., Van Kampen G., and Van der Korst J. (1990). Composition of proteoglycans synthesized in different layers of cultured anatomically intact articular cartilage. Matrix10: 394-401.
56.
Lamar CH, Van Sickle DC, Brandman P., and Hinsman EJ (1980). Ultrastructure of timed isolates of in vitro canine articular chondrocytes. Am. J. Vet. Res. 41: 241-243.
57.
Machida M., Kusajima H., Aijima H., Maeda A., Ishida R., and Ucida H. (1990). Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol. Appl. Pharmacol. 105: 403-412.
58.
Maggiolo F. , Caprioli S., and Suter F. (1990). Risk/ benefit analysis of quinolone use in children: The effect on diarthrodial joints. J. Antimicrob. Chemother. 26(4): 469-471.
59.
Malemud CJ (1991). Changes in proteoglycans in osteoarthritis: Biochemistry, ultrastructure and biosynthetic processing. J. Rheumatol. Suppl. 27: 60-62.
60.
Mankin HJ (1964). Mitosis in articular cartilage of immature rabbits . Clin. Orthop. 34: 170-183.
61.
Mankin H., Dorfman H., and Lippiello L. (1971). Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg. 53: 523-537.
62.
Mankin HJ and Lippiello L. (1970). Biochemical and metabolic abnormalities in articular cartilage from oster-arthritic human hips. J. Bone Joint Surg . 52A: 424-434.
63.
Mankin HJ and Treadwell BV (1986). Osteoarthritis: A 1987 update. Bull. Rheum. Dis. 36(5): 1-10.
64.
Maroudas A. (1979). Physiochemical properties of articular cartilage . In: Adult Articular Cartilage, M Freeman (ed). Saunders, North Ryde, Aus, pp. 215-290.
65.
Martel-Pelletier J., Pelletier JP, Cloutier JM, Howell DS, Ghandur-Mnaymneh L., and Woessner JF (1984). Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum. 27: 305-312.
66.
Martel-Pelletier, Pelletier JP, and Malemud CJ (1988). Activation of neutral metalloprotease in human osteoarthritic knee cartilage: Evidence for degradation of the core protein of sulfated proteoglycan. Ann. Rheum. Dis. 47: 801-808.
67.
Mayne R. (1989). Cartilage collagens. Arthritis Rheum. 32(3): 241-246.
68.
McDevitt CA and Muir H. (1976). Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog. J. Bone Joint Surg. 58B: 94-101.
69.
Meachim G. and Stockwell RA (1979). The matrix. In: Adult Articular Cartilage, M Freeman (ed). Saunders, North Ryde, Aus, pp. 1-67.
70.
Monk JP and Campoli-Richards DM (1987). Ofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use . Drugs33: 346-391.
71.
Moriguchi T. and Fujimoto D. (1978). Age-related changes in the content of the collagen cross-link, pyridinoline. J. Biochem . 84: 933-935.
72.
Moskowitz RW , Davis W., Sammarco J., Martens M., Baker J., Mayor M., Burstein AH, and Frankel VH (1973). Experimentally-induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum. 16: 397-405.
73.
Murphy G., Hembry RM, Hughes CE, Fosang AJ, and Hardingham TE (1990). Role and regulation of metalloproteinases in connective tissue turnover. Biochem. Soc. Trans. 18: 812-815.
74.
Nakano T., Thompson JR, and Aherne FX (1983). Growth-dependent changes in the content of the collagen crosslink, pyridinoline, in joint cartilage from pigs. Can. J. Anim. Sci. 63: 677-681.
75.
Nguyen Q., Murphy G., Roughley PJ, and Mort JS (1989). Degradation of proteoglycan aggregate by a cartilage metalloproteinase: Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. J. Biochem. 259: 61-67.
76.
Okada Y., Gonoji Y., Nakanishi I., Nagase H., and Hayakawa T. (1990). Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch. B Cell: Pathol. 59: 305-312.
77.
Okazaki O., Kurata T., Hashimoto K., Sudo K., Tsumura M., and Tachizawa H. (1984). Metabolic disposition of DL-8280. The second report: Absorption, distribution and excretion of 14C-D 1-8280 in various animal species . Chemotherapy32(suppl.1): 1185-1202.
78.
Palmoski MJ and Brandt KD (1983). In vivo effect of aspirin on canine osteoarthritic cartilage. Arthritis Rheum . 26: 994-1001.
79.
Palmoski M. , Williams P., Laska D., and Bean J. (1988). Effects of quinolones on proteoglycans (PGs) in adult and juvenile canine cartilage. Toxicologist8(1): 40.
80.
Pelletier J. , Martel-Pelletier J., and Malemud C. (1988). Canine osteoarthritis: Effects of endogenous neutral metalloproteoglycanases on articular cartilage proteoglycans. J. Orthop. Res. 6: 379-388.
81.
Phadke K. (1983). Regulation of metabolism of the chondrocytes in articular cartilage-An hypothesis. J. Rheumatol. 10: 852-860.
82.
Pond MJ and Nuki G. (1973). Experimentally-induced osteoarthritis in the dog . Ann. Rheum. Dis. 32: 387-388.
83.
Poole AR, Pidoux I., Reiner A., and Rosenberg L. (1982). An immunoelectron microscope study of proteoglycan monomer, link protein and collagen of articular cartilage. J. Cell Biol. 93: 921-937.
84.
Ramachandran I. (1967). A Treatise on Collagen, Vol. 1. Academic Press, New York , p. 556.
85.
Rosen T. (1990). The fluoroquinolone antibacterial agents. Prog. Med. Chem. 27: 235-295.
86.
Roughley PJ and Barrett AJ (1977). The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis. Biochem. J. 167: 629-637.
87.
Roughley PJ , Nguyen Q., and Mort J. (1991). Mechanisms of proteoglycan degradation in human articular cartilage. J. Rheumatol. Suppl . 27: 52-54.
88.
Rouslahti E. (1988). Structure and biology of proteoglycans. Ann. Rev. Cell Biol. 4: 229-255.
89.
Ruggeri A. and Motta PM (1984). Ultrastructure of the Connective Tissue Matrix , 1sted. Martinus Nijhoff Publishers, Norwell, MA, p. 217.
90.
Salter RB and Field P. (1960). The effects of continuous compression on living cartilage. J. Bone Joint Surg. 42: 31-49.
91.
Schaad UB and Wedgood-Krucko J. (1987). Nalidixic acid in children: Retrospective matched controlled study for cartilage toxicity. Infection15(3): 165-168.
92.
Schacht P., Arcieri G., and Hullman R. (1989). Safety of ciprofloxacin. Am. J. Med.87(suppl. 5A): 98S-102S.
93.
Schwartz ER (1982). An animal model of osteoarthritis: Surgically induced osteoarthritis in the guinea pig. In: Experimental Biology and Medicine. Vol. 7. Research Animals and Concepts of Applicability to Clinical Medicine, K Gartner and H Hackbarth (eds). Karger Basel, pp. 231-232.
94.
Schwartz ER , Oh WH, and Leveille CR (1981). Experimentally induced osteoarthritis in guinea pigs: Metabolic responses in articular cartilage to developing pathology. Arthritis Rheum. 24: 1345-1355.
95.
Shen LL, Kohlbrenner WE, Weigl D., and Baranowski J. (1989). Mechanism of quinolone inhibition of DNA gyrase . J. Biol. Chem. 264: 2973-2978.
96.
Siporin C. , Heifetz CL, and Domagala JM (1990). The New Generation of Quinolones. Marcel Dekker, New York, p. 347.
97.
Sokoloff L. (1980). The Joints and Synovial Fluid, Vol. II, 1st ed. Academic Press, New York, p. 561.
98.
Springman EB , Angelton EL, Birkedal-Hansen H., and Van Wart HE (1990). Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. USA87: 364-368.
99.
Stahlmann R. (1990). Safety profile of the quinolones . J. Antimicrob. Chemother.26(suppl. D): 31-44.
100.
Stahlmann R. (1991). Cartilage-damaging effect of quinolones. Infection19(suppl.1): S38-S46.
101.
Stahlmann R., Merker HJ, Hinz N., Chahoud I., Webb J., Heger W., and Neubert D. (1990). Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch. Toxicol. 64: 193-204.
102.
Stockwell RA and Meachim G. (1979). The chondrocytes . In: Adult Articular Cartilage, MAR Freeman (ed). Saunders, North Ryde, Aus, pp. 69-144.
103.
Sudo K., Hashimoto K., Kurata T., Okazaki O., Tsumuro M., and Tachizawa H. (1984). Metabolic disposition of DL-8280. The third report: Metabolism of 14c-D1-8280 in various animal species. Chemotherapy32(suppl.1): 1203-1216.
104.
Sudo K., Ikazaki O., Tsumura M., and Tachizawa H. (1986). Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys. Xenobiotica16: 725-732.
105.
Tatsumi H. , Senda H., Yatera S., Takemoto Y., Yamayoshi M., and Ohnishi K. (1978). Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals . J. Toxicol. Sci. 3: 357-367.
106.
van der Rest M. (1990). From the gene to the protein: The discovery of type XII collagen. In: Methods in Cartilage Research, A Maroudas and K Kuettner (eds). Academic Press, San Diego, pp. 190-194.
107.
Weissmann G., Pras M., and Rosenberg L. (1967). Arthritis produced by Filipin in rabbits. Arthritis Rheum . 10: 325-336.
108.
Williams JM and Brandt KD (1982). Iodoacetate causes osteoarthritis in guinea pigs. Anat. Rec.202: 204A.
109.
Woessner J. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
110.
Woessner J. and Gunja-Smith Z. (1991). Role of metalloproteinases in human osteoarthritisJ. Rheumatol. Suppl. 27: 99-101.
111.
Zanetti M. , Ratchliffe A., and Watt F. (1985). Two subpopulations of differentiated chondrocytes identified with a monoclonal antibody to keratan sulfate. J. Cell Biol. 101: 53-59.
